Recent Posts



  • Why do you care?
    You care so much about things that don’t pertain to you & it’s rooted in jealousy.

    You care about the FRM salary, you care about FRMs being cut in the future, you care about Kite getting shopped, you care about the PrEP EDs, you care about stuff that Dan is paid handsomely to think through.

    Focus on you.
    WTH is this poster comment talking about?
    From what I see this is about Kite, nothing is even mentioned about FRM (whatever that is) or Prep EDs.
    This cat must be a paranoid and hallucinating. Get off the crack.

anonymous
Jun 04, 2025 at 07:11 AM
  • Close but you’re still wrong.

    Business Development:
    HIV Expansion

    Account Management:
    Kite/Oncology

    Specialty Rep:
    Liver & maybe HIV Treatment

    Primary Care:
    PrEP

    Business Development reps operate at a higher level of influence than Account Management Oncology because BD isn’t just influencing treatment decisions, they’re creating them.

    Account Management reps engage physicians who are already trained to treat aggressively. The demand exists. The clinical mindset to treat, is already there. The only challenge is medication differentiation, not behavior change.


    Business Development reps face a much harder mission:

    1. Turning non-treaters into treaters

    2. Changing clinical behavior where no action was previously taken

    3. Building prescriber belief from the ground up


    This requires a mastery of clinical education, influence & objection handling, within IDNs, Hospital owned Physician Practices/Hospital Pharmacy Pull Through & large/complex independent group practices in markets with high resistance.

    Oncology reps, although highly trained, have expertise in account management & competitive positioning. Valuable, yes, but not easily transferable to roles that require building demand from zero.

    Bottom line:
    Oncology reps build market share, Business Development reps build new markets
    This is the most waste of a written dissertation on 100% miss information that I have read and obvious a person not associated as a current employee because HIV Business Development as you call it (that is not the name we are using) has not been completely defined yet.
    RDs just started interviewing this week and reps are posted but not scheduled to interview until July.

    Being involved in the build out process, pending label approval, we will call on low decile non-HIV writers.
    Primary Care, Internal Medicine, Family Practice who have never written HIV products. Pending label, could add OBGYNs to the mix.
    We will only have 35 Reps thus are based on the top undeserved HIV populated markets.
    It is truly an entry level position. The pay band will reflect this targeting 120k range for reps.

anonymous
Jun 04, 2025 at 07:04 AM
  • So apparently the new requirement for hiring in the TEP team is multiple presidents club wins. Just curious how many people in the current salesforce wouldn’t qualify for their own job now!?

anonymous
Jun 04, 2025 at 07:02 AM
anonymous
Jun 04, 2025 at 06:52 AM
  • It’s funny how quiet it is on here after the big announcement in April. Afraid someone might be listening?

anonymous
Jun 04, 2025 at 06:48 AM